Affimed N.V. Long Term Debt Current | AFMD

Annual Long Term Debt Current Affimed N.V.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
539 K	396 K	683 K	492 K	532 K	-	-	-	-	-	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
683 K	396 K	528 K

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
ERYTECH Pharma S.A. ERYP	775 K	-	1.3 %	$ 27.7 M	France
Liminal BioSciences LMNL	735 K	-	-	$ 256 M	Canada
argenx SE ARGX	10.8 M	$ 977.91	0.65 %	$ 59.9 B	Niderland
Viridian Therapeutics VRDN	753 K	$ 31.22	1.17 %	$ 3.18 B	USA
Zealand Pharma A/S ZEAL	14.9 M	-	0.52 %	$ 821 M	Danmark
Vanda Pharmaceuticals VNDA	2.15 M	$ 4.17	2.08 %	$ 246 M	USA
Verrica Pharmaceuticals VRCA	341 K	$ 3.88	10.23 %	$ 41.3 M	USA
Leap Therapeutics LPTX	38 K	-	368.57 %	$ 41.9 M	USA
Zymeworks ZYME	1.31 M	$ 29.06	-7.64 %	$ 1.5 B	Canada
ADMA Biologics ADMA	1.1 M	$ 13.19	4.1 %	$ 3.14 B	USA
Cortexyme CRTX	115 K	-	-1.05 %	$ 67.1 M	USA
Daré Bioscience DARE	603 K	$ 0.71	2.5 %	$ 7.94 M	USA
Fate Therapeutics FATE	4.56 M	$ 1.6	-9.6 %	$ 190 M	USA
Halozyme Therapeutics HALO	13.3 M	$ 101.68	-1.26 %	$ 12.2 B	USA
Hutchison China MediTech Limited HCM	2.88 M	$ 15.09	-1.92 %	$ 13 B	China
Aptorum Group Limited APM	24.4 K	-	-	$ 5.72 M	China
iBio IBIO	546 K	$ 0.82	5.55 %	$ 85.3 M	USA
Kodiak Sciences KOD	12.1 M	$ 109.34	1.18 %	$ 5.82 B	USA
Karyopharm Therapeutics KPTI	969 K	$ 0.02	-56.5 %	$ 219	USA
FSD Pharma HUGE	103 K	-	5743.5 %	$ 69.7 M	Canada
BioAtla BCAB	1.43 M	$ 1.74	0.64 %	$ 102 M	USA
Catalyst Pharmaceuticals CPRX	437 K	-	-	$ 3.85 B	USA
UroGen Pharma Ltd. URGN	481 K	$ 26.14	3.24 %	$ 1.26 B	Israel
Catalyst Biosciences CBIO	636 K	$ 14.79	6.25 %	$ 1.32 B	USA
ARCA biopharma ABIO	619 K	-	1052.0 %	$ 415 M	USA